Inflammation, carcinogenesis and cancer

Area of Science:

• Immunology
• Oncology
• Genetics

Background:

• Granulocytes produce reactive oxidants and electrophiles for host defense, which can be genotoxic to host tissues.
• Prolonged inflammation (over a decade) is linked to increased cancer risk, detectable in epidemiological studies.
• Recent antioxidant trials yielded disappointing results, prompting re-evaluation of endogenous genotoxic agents.

Purpose of the Study:

• To assess molecular and cellular models of inflammation-induced cancer risk.
• To investigate the role of specific endogenous genotoxic agents like hydrogen peroxide and oxy radicals.
• To explore alternative hypotheses regarding cancer development, focusing on epigenetic modifications.

Main Methods:

• Review of molecular and cellular mechanisms linking inflammation to genotoxicity.
• Analysis of findings from recent clinical trials involving antioxidant interventions.
• Evaluation of hypotheses involving epigenetic inactivation of tumor suppressor genes.

Main Results:

• Endogenous genotoxic agents from inflammation pose a risk to genomic integrity.
• Antioxidant interventions have shown limited success in mitigating inflammation-associated cancer.
• Epigenetic inactivation of tumor suppressors, such as p53, is proposed as a key mechanism.

Conclusions:

• Chronic inflammation contributes to cancer risk through genotoxic mechanisms.
• The failure of antioxidant trials suggests a need for alternative therapeutic and research strategies.
• Epigenetic alterations, particularly of tumor suppressors, represent a significant factor in inflammation-driven carcinogenesis.